Last quarter (Q0 0), BioRegenx's total revenue was $596.04K, an increase of 16052.76% from the same quarter last year. In Q0, BioRegenx's net income was $-394.86K. See BioRegenx’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 04
Total Revenue	$ 1.95M	$ 22.24K	$ 42.16K	$ 198.58K	$ 368.52K	$ ―
Cost of Revenue	$ 537.89K	$ ―	$ ―	$ 554.00	$ 3.23K	$ ―
Gross Profit	$ 1.42M	$ 22.24K	$ 42.16K	$ 198.03K	$ 365.30K	$ ―
Operating Expense	$ 3.43M	$ 131.91K	$ 120.47K	$ 363.15K	$ 580.94K	$ 224.27K
Operating Income	$ -2.02M	$ -109.66K	$ -78.31K	$ -165.12K	$ -215.65K	$ -224.27K
Net Non Operating Interest Income Expense	$ -204.02K	$ -8.28K	$ ―	$ ―	$ ―	$ ―
Other Income Expense	$ ―	$ 453.23K	$ ―	$ 68.25K	$ -58.09K	$ ―
Pretax Income	$ -3.44M	$ -571.17K	$ -78.31K	$ -96.87K	$ -273.74K	$ ―
Tax Provision	$ ―	$ ―	$ ―	$ 0.00	$ 0.00	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -2.16M	$ -552.38K	$ -78.31K	$ -96.87K	$ -273.74K	$ -224.27K
Basic EPS	$ ―	$ ―	$ ―	$ >-0.01	$ >-0.01	$ 0.00
Diluted EPS	$ ―	$ ―	$ ―	$ >-0.01	$ >-0.01	$ 0.00
Basic Average Shares	$ 2.97B	$ 276.37M	$ 269.75M	$ 269.75M	$ 267.96M	$ 21.20K
Diluted Average Shares	$ 3.02B	$ 276.37M	$ 269.75M	$ 269.75M	$ 267.96M	$ 32.15K
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 3.97M	$ 131.91K	$ 120.47K	$ 363.70K	$ 584.17K	$ 224.27K
Net Income From Continuing And Discontinued Operation	$ -2.22M	$ -571.17K	$ -78.31K	$ -96.87K	$ -273.74K	$ -224.27K
Normalized Income	$ -3.39M	$ ―	$ -61.86K	$ -96.87K	$ -215.65K	$ -224.27K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -2.02M	$ -562.89K	$ -25.39K	$ -165.12K	$ -215.65K	$ -224.27K
EBITDA	$ -345.09K	$ -556.96K	$ -19.46K	$ -160.67K	$ -209.72K	$ -224.27K

Currency in USD

BioRegenx Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing